ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 37 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,000 | -34.3% | 9,044 | -9.6% | 0.00% | – |
| Q2 2020 | $35,000 | -31.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2020 | $51,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2019 | $51,000 | -19.0% | 10,000 | -50.0% | 0.00% | – |
| Q3 2019 | $63,000 | -11.3% | 20,000 | 0.0% | 0.00% | – |
| Q2 2019 | $71,000 | -1.4% | 20,000 | 0.0% | 0.00% | – |
| Q1 2019 | $72,000 | +20.0% | 20,000 | 0.0% | 0.00% | – |
| Q4 2018 | $60,000 | -38.1% | 20,000 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -34.9% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $149,000 | -17.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $180,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $180,000 | -9.1% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $198,000 | +7.6% | 20,000 | -33.3% | 0.00% | 0.0% |
| Q2 2017 | $184,000 | 0.0% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $184,000 | +1126.7% | 30,000 | +2900.0% | 0.00% | – |
| Q4 2013 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |